Speciality Medicines Ltd.

The Speciality Medicines Ltd. IPO has a total issue size of ₹29 crore, calculated at the upper end of the price band.

The Speciality Medicines Ltd. IPO is priced at ₹117–124 per share. Retail bids must fall within this price band, against a face value of ₹10 per share.

The lot size for the Speciality Medicines Ltd. IPO is 2,000 shares, which is also the minimum order quantity — you have to apply for at least 2,000 shares, and in multiples of 2,000 beyond that.

The minimum investment in the Speciality Medicines Ltd. IPO is about ₹2,34,000 — one lot of 2,000 shares, calculated at the lower end of the price band.

Bidding at the cut-off or upper price raises the amount blocked in your account.

The Speciality Medicines Ltd. IPO opens on 20 Mar 2026 and closes on 24 Mar 2026.

Applications have to be in before 5:00 PM IST on the closing day, and your UPI mandate needs to be approved by then as well.

Speciality Medicines Ltd. shares were listed on 30 Mar 2026 on BSE.

Skyline Financial Services Pvt Ltd is the registrar for the Speciality Medicines Ltd. IPO.

The registrar processes the basis of allotment, refunds and the credit of shares to your demat account, so allotment-status queries go to them — phone 91-011-26812682/84 and email admin@skylinerta.com.

Speciality Medicines Ltd. IPO shares are listed on BSE.

Each Speciality Medicines Ltd. share has a face value of ₹10.

Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.

Promoters held 62.16% of Speciality Medicines Ltd. before the IPO, which falls to 43.43% after the issue.

23,50,000 shares of Speciality Medicines Ltd. are being offered to the public in this issue.

The Speciality Medicines Ltd. IPO has been subscribed 2.19x overall — QIB 96.24x, NII 1.77x and retail 0.85x.

Subscription figures update through the issue period until it closes.

1. 1.Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje: Manda, Tal. Umargam, Dist. Valsad, Gujarat
2. 2.Product Registration in International Markets and Product Development for sale in international markets
3. 3.Funding for Marketing and Promotional Activities
4. 4.To Meet Working Capital Requirements
5. 5.General Corporate Purpose

Unistone Capital Pvt Ltd. is the book running lead manager for the Speciality Medicines Ltd. IPO.

Pre-apply means placing your Speciality Medicines Ltd. IPO application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.

Applying early doesn't improve your chances — when an issue is oversubscribed, the basis of allotment for retail investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.

You can apply in the Speciality Medicines Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.

Either route needs a demat account. You bid for at least one lot, at a price within the price band or at the cut-off price, and the money stays blocked in your bank account until the basis of allotment is finalised.

Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.

You can check the Speciality Medicines Ltd. IPO bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.